The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
![Brazil Brazil flag](https://www.greenhill.com/sites/default/files/brazil.gif)
Policard
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Advised Policard, one of the largest electronic payment companies in Brazil, on the combination of its business with the Brazilian operations of Groupe Up, one of the leading employee benefits, public, social and loyalty programs providers in the world
![Brazil Brazil flag](https://www.greenhill.com/sites/default/files/brazil.gif)
Recepta Biopharma
![Brazil Brazil flag](https://www.greenhill.com/sites/default/files/brazil.gif)
Advised Recepta Biopharma on a capital raise
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Air Warfare Destroyer Reform Strategy
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised the Commonwealth Government of Australia as represented by the Department of Finance in relation to the Air Warfare Destroyer Reform Strategy
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Allied Healthcare
![Germany Germany flag](https://www.greenhill.com/sites/default/files/germany.gif)
Advised Saga plc on the disposal of Allied Healthcare, the leading local authority-funded domiciliary care business in the UK, to AURELIUS Investments
![Ireland Ireland flag](https://www.greenhill.com/sites/default/files/ireland.gif)
Allergan Generics
![Israel Israel flag](https://www.greenhill.com/sites/default/files/israel.gif)
Advised Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, on the acquisition of Allergan plc’s Generics business
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Portfolio of GlaxoSmithKline plc consumer and OTC brands
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised GlaxoSmithKline plc, a leading British pharmaceutical company, on the disposal of a portfolio of consumer and OTC brands to Omega Pharma NV, a subsidiary of Perrigo Company plc
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Refinancing of syndicated bank debt facilities
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advised Primary Health Care on the refinancing of its A$1.25 billion syndicated bank debt facilities
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
John Laing plc
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised Henderson Equity Partners on the initial public offering of John Laing plc, a leading originator, active investor and manager of international infrastructure projects
![Japan Japan flag](https://www.greenhill.com/sites/default/files/japan.gif)
Hitachi Appliances, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Hitachi, LTD / Hitachi Appliances, Inc, a leading global industrial conglomerate focused on information and telecommunications systems, power systems and social systems, on their formation of a global HVAC joint venture with Johnson Controls
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
NYK Ports LLC
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advised NYK Ports LLC, a leading port operating and stevedoring company, on the sale of a 49% stake to Macquarie Infrastructure Partners, a leading Australian infrastructure fund
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Clinuvel Pharmaceuticals Limited
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Clinuvel, a biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders, in response to an unsolicited proposal to acquire the business from Retrophin, a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Frank Russell Company
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advised LSEG on the proposed acquisition of Frank Russell Company, the number one provider of benchmarks to US-focused equity funds and a leading provider of multi-asset class investment solutions, from Northwestern Mutual Life Insurance Company, including acting as Joint Sponsor to LSEG on its $1.6 billion rights issue
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Essar Energy plc
![Cayman Islands flag](https://www.greenhill.com/sites/default/files/cayman-islands_36471.gif)
Advised the Independent Committee of the Board of Essar Energy plc in connection with possible offers from Essar Global Fund Limited, its 78% shareholder, for the remaining shares it does not already own and $550mm convertible bonds issued by Essar Energy plc
![Sweden Sweden flag](https://www.greenhill.com/sites/default/files/sweden.gif)
Unfors Raysafe AB
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised the Sixth Swedish National Pension Fund on the sale of Unfors Raysafe AB, a provider of easy-to-use products that help to reduce unnecessary radiation exposure, to Fluke Biomedical Corp., a subsidiary of Danaher Corp. that manufactures biomedical test and simulation products
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
iSelect (30% shareholding)
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advised Mi9, a joint venture between Microsoft and Nine Entertainment Co, and one of Australia’s leading digital media companies, on the sale of its 30% holding in iSelect, a leading Australian online-driven comparison service, as part of the Initial Public Offering of iSelect
![Ireland Ireland flag](https://www.greenhill.com/sites/default/files/ireland.gif)
Warner Chilcott, plc
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Actavis, Inc., a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, branded and biosimilar products on its acquisition of Warner Chilcott plc
![Japan Japan flag](https://www.greenhill.com/sites/default/files/japan.gif)
Sanyo DI Solution
![Japan Japan flag](https://www.greenhill.com/sites/default/files/japan.gif)
Advised Advantage Partners, a leading private equity fund in Japan, on the acquisition of 100% stake in Sanyo DI Solution, the digital still camera OEM business in SANYO Electric, a group company of Panasonic
![Germany Germany flag](https://www.greenhill.com/sites/default/files/germany.gif)
Germanischer Lloyd
![Norway Norway flag](https://www.greenhill.com/sites/default/files/nor.gif)
Advised Det Norske Veritas on its merger with Germanischer Lloyd to create the third largest player in the Testing, Inspection and Certification industry, focused on ship classification, oil & gas and energy
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Aurelian Oil & Gas PLC
![Ireland Ireland flag](https://www.greenhill.com/sites/default/files/ireland.gif)
Advised Aurelian Oil & Gas, an AIM-listed E&P company primarily focused on natural gas exploration in Central Europe, on its recommended merger with AIM-listed peer San Leon Energy PLC
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Moorebank Intermodal Terminal
Acted as independent advisor to the Australian Government in a peer review of the proposed intermodal terminal linking Sydney’s major port with Australia’s road and rail system
![UK/Ireland U.K., Ireland flags](https://www.greenhill.com/sites/default/files/uk-ireland_35558.gif)
Viridian Group
Advised the Board of Viridian, the leading energy utility company in the all-Ireland market, on its refinancing comprising the issue of €313 million and $250 million notes due April 2017
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
iNova Pharmaceuticals
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Archer Capital and Ironbridge Capital on the sale of iNova Pharmaceuticals, a leading pharmaceuticals company that sells and distributes a range of prescription and over-the-counter products in Australia, New Zealand, Asia and Southern Africa, to Valeant Pharmaceuticals
![Japan Japan flag](https://www.greenhill.com/sites/default/files/japan.gif)
Diabetes-related patent estate and royalty stream of Astellas Pharma subsidiary, Prosidion
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Royalty Pharma, a leading acquiror of biopharmaceutical royalty interests, on the acquisition of the DPP-IV patent estate and associated royalty stream of Astellas Pharma subsidiary, Prosidion
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Bionomics Ltd
Advised Bionomics Ltd, in relation to the tender process run by Bionomics’ largest shareholder, Start-up Australia Ventures (“Start-up”), for its 28% stake in the company, follow on sell-down of Start-up’s stake to 8% and associated capital raising by Bionomics
![Norway Norway flag](https://www.greenhill.com/sites/default/files/nor.gif)
Aker Solutions (Aker Holding)
![Norway Norway flag](https://www.greenhill.com/sites/default/files/nor.gif)
Advised the Norwegian Government on strategic and financial matters in relation to its investment in Aker Holding, the largest shareholder of Aker Solutions during the demerger of the company’s EPC activities